WINT insider filings
WINDTREE THERAPEUTICS INC /DE/ — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-10-09. Screen WINT transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for WINT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — WINDTREE THERAPEUTICS INC /DE/
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-10-09 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 5,431 @ $0.91 | EDGAR |
| 2024-07-24 | 4 | Simonson Steven — SVP, Chief Medical Officer | Grant/award (A): 13 (derivative) · Grant/award (A): 2,674 (derivative) | EDGAR |
| 2024-07-24 | 4 | Fraser Craig — President and CEO, Director | Grant/award (A): 19 (derivative) · Grant/award (A): 4,011 (derivative) | EDGAR |
| 2023-09-28 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 2,500 @ $1.02 | EDGAR |
| 2023-09-27 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 2,500 @ $0.90 | EDGAR |
| 2023-08-29 | 4 | Geffken Daniel E. — Director | Grant/award (A): 2,033 @ $0 · Grant/award (A): 3,050 (derivative) @ $0 | EDGAR |
| 2023-08-25 | 4 | Williams Leslie J. — Director | Grant/award (A): 2,033 @ $0 · Grant/award (A): 3,050 (derivative) @ $0 | EDGAR |
| 2023-08-25 | 4 | Curtis Eric — SVP & COO | Grant/award (A): 14,667 @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2023-08-25 | 4 | Simonson Steven — SVP, Chief Medical Officer | Grant/award (A): 15,867 @ $0 · Grant/award (A): 23,800 (derivative) @ $0 | EDGAR |
| 2023-08-25 | 4 | Strobeck Mark — Director | Grant/award (A): 2,300 @ $0 · Grant/award (A): 3,450 (derivative) @ $0 | EDGAR |
| 2023-08-25 | 4 | Fraser Craig — President and CEO, Director | Grant/award (A): 45,867 @ $0 · Grant/award (A): 68,800 (derivative) @ $0 | EDGAR |
| 2023-08-25 | 4 | SCOTT ROBERT A — Director | Grant/award (A): 2,033 @ $0 · Grant/award (A): 3,050 (derivative) @ $0 | EDGAR |
| 2023-04-27 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 1,497 @ $1.77 | EDGAR |
| 2023-04-26 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 1,315 @ $1.89 | EDGAR |
| 2023-03-02 | 4 | CARMAN DIANE — SVP & General Counsel | Tax withholding (F): 99 @ $0 | EDGAR |
| 2023-03-02 | 4 | Curtis Eric — SVP & COO | Tax withholding (F): 99 @ $0 | EDGAR |
| 2023-03-02 | 4 | Simonson Steven — SVP, Chief Medical Officer | Tax withholding (F): 100 @ $0 | EDGAR |
| 2023-03-02 | 4 | Fraser Craig — President and CEO, Director | Tax withholding (F): 334 @ $0 | EDGAR |
| 2023-02-23 | 4 | Huang James — Director | Option exercise/expiry (X): 1,112,308 @ $0.14 · Disposition to issuer (D): 275,862 (derivative) @ $0 · Disposition to issuer (D): 275,938 (derivative) @ $0 · Disposition to issuer (D): 498,008 (derivative) @ $0 · Disposition to issuer (D): 62,500 (derivative) @ $0 · Grant/award (A): 1,112,308 (derivative) @ $0 · +2 more | EDGAR |
| 2022-07-27 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 2,500 @ $0.38 | EDGAR |
| 2022-07-26 | 4 | Hamill John P. — SVP & CFO | Purchase (P): 3,000 @ $0.37 | EDGAR |
| 2022-07-26 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 2,500 @ $0.37 | EDGAR |
| 2022-07-05 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 4,500 @ $0.43 | EDGAR |
| 2022-06-30 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 7,000 @ $0.42 | EDGAR |
| 2022-06-09 | 4 | Williams Leslie J. — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Huang James — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Geffken Daniel E. — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | SCOTT ROBERT A — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2022-03-17 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 2,000 @ $0.98 | EDGAR |
| 2022-03-15 | 4 | Simonson Steven — SVP, Chief Medical Officer | Purchase (P): 5,000 @ $1.00 | EDGAR |
| 2022-03-15 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 3,000 @ $0.98 | EDGAR |
| 2022-03-07 | 4 | CARMAN DIANE — SVP & General Counsel | Grant/award (A): 66,300 @ $0 · Grant/award (A): 99,600 (derivative) @ $0 | EDGAR |
| 2022-03-07 | 4 | Hamill John P. — SVP & CFO | Grant/award (A): 66,300 @ $0 · Grant/award (A): 99,600 (derivative) @ $0 | EDGAR |
| 2022-03-07 | 4 | Curtis Eric — SVP & COO | Grant/award (A): 66,300 @ $0 · Grant/award (A): 99,600 (derivative) @ $0 | EDGAR |
| 2022-03-07 | 4 | Simonson Steven — SVP, Chief Medical Officer | Grant/award (A): 66,300 @ $0 · Grant/award (A): 99,600 (derivative) @ $0 | EDGAR |
| 2022-03-07 | 4 | Fraser Craig — President and CEO, Director | Grant/award (A): 166,900 @ $0 · Grant/award (A): 250,400 (derivative) @ $0 | EDGAR |
| 2022-01-10 | 4 | Center Laboratories, Inc. — 10% owner | Other (J): 3,551,750 @ $0 · Purchase (P): 55,172 @ $7.25 · Purchase (P): 1,239,088 @ $1.60 · Other (J): 0 (derivative) @ $0 · Other (J): 249,004 (derivative) @ $0 · Purchase (P): 55,172 (derivative) @ $0 | EDGAR |
| 2022-01-10 | 4 | Bioengine Capital Inc. — 10% owner | Other (J): 3,551,750 @ $0 · Purchase (P): 55,172 @ $7.25 · Sale (S): 1,239,088 @ $1.60 · Other (J): 0 (derivative) @ $0 · Other (J): 249,004 (derivative) @ $0 · Purchase (P): 55,172 (derivative) @ $0 | EDGAR |
| 2021-11-22 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 930 @ $1.60 | EDGAR |
| 2021-11-18 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 930 @ $1.61 | EDGAR |
| 2021-10-25 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 3,000 @ $1.90 | EDGAR |
| 2021-10-19 | 4 | Huang James — Director | Purchase (P): 50,000 @ $1.90 | EDGAR |
| 2021-10-19 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 3,000 @ $1.91 | EDGAR |
| 2021-07-06 | 4 | CARMAN DIANE — SVP & General Counsel | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Huang James — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Geffken Daniel E. — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-04-20 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 1,000 @ $2.09 | EDGAR |
| 2021-04-19 | 4 | Hamill John P. — SVP & CFO | Purchase (P): 1,000 @ $2.07 | EDGAR |
| 2021-04-19 | 4 | Fraser Craig — President and CEO, Director | Purchase (P): 1,000 @ $2.24 | EDGAR |
| 2021-04-08 | 4 | Curtis Eric — SVP & COO | Purchase (P): 791 @ $2.52 | EDGAR |
Recent 8-K events — WINDTREE THERAPEUTICS INC /DE/
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-02 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-16 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-09-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-08-20 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-08-08 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-08-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=WINT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs